Listeria Treatments

Listeria is a genus of small, motile gram-positive bacilli that infect many types of animals and contaminates numerous foods – including vegetables, chicken, milk, and beef. The most important species of the genus, Listeria monocytogenes, is an important cause of foodborne illness that disproportionately affects pregnant women and their newborns.

Listeria Bacteria

Listeria Bacteria. Image Credit: Negro Elkha/

Due to its high mortality rate, ongoing efforts are needed to further reduce the incidence of listeriosis. Proper storage and handling of refrigerated ready-to-eat foods can help reduce the risk of listeriosis; if the disease develops, assessing its severity is essential before antimicrobial therapy is instituted.

Management of the disease

Febrile gastroenteritis due to Listeria monocytogenes is self-limited, with a typical duration of fewer than 2 days; hence in most instances, antimicrobial treatment is not warranted. Nevertheless, antibiotics should be introduced as early as possible in cases of bacteremia as the disease can be severe with high mortality rates.

An antibiotic of choice should be able to enter the host cells, bind to the penicillin-binding protein 3 (PBP3) of Listeria, and remain active in the hostile intracellular environment. Listeria strains are generally susceptible to the clinically important antibiotics, albeit usually resistant to cephalosporins.

Based on in vitro susceptibility testing, animal studies and case reports, ampicillin and penicillin (often in combination with gentamicin) represent first-line therapy of invasive listeriosis, especially in patients older than 50. In immunocompromised individuals, the addition of rifampicin helps to eradicate the remaining bacteria and cure the infection.

An adequate dose is also important. Knowing that Listeria monocytogenes has a high affinity for the central nervous system, the dosages of drugs intended for patients with listerial meningitis should be used for all individuals with listeriosis – even in the absence of proven neuroinvasive disease.

For patients intolerant or allergic to penicillin, trimethoprim-sulfamethoxazole is considered to be the best alternative single agent. Certain animal studies and in vitro data suggest a potential role for the newer fluoroquinolones, but clinical data are lacking.

Clinically significant antimicrobial resistance isolates of Listeria monocytogenes have not been encountered, but vigilance is warranted. Several research groups have identified putative genetic loci that may regulate tolerance to bacteriocins, ampicillin, and penicillin, and the transfer of resistance from enterococci has been documented.

Prevention of listeriosis

Most effective strategies to control Listeria in high-risk foods include good manufacturing practices, time and temperature controls throughout the entire distribution and storage period, as well as adequate post packaging treatments to minimize environmental Listeria monocytogenes contamination and to destroy this microorganism on products.

High-risk individuals (i.e. pregnant women, the elderly, and immunocompromised individuals) should be given thorough instructions on healthy eating, including specific information on high-risk foods that they should avoid, and strategies to reduce their risk (such as thorough cooking, avoidance of cross-contamination, and short-term refrigerated storage of cooked foods).

Science-based education and risk communication strategies aimed at vulnerable populations and focused on high-risk foods should be delivered through health care providers or other trustworthy sources of information. If pregnant women are unfamiliar with the possible consequences of contracting Listeria, the mother and child are in danger of health complications.


Further Reading

Last Updated: Feb 17, 2021

Dr. Tomislav Meštrović

Written by

Dr. Tomislav Meštrović

Dr. Tomislav Meštrović is a medical doctor (MD) with a Ph.D. in biomedical and health sciences, specialist in the field of clinical microbiology, and an Assistant Professor at Croatia's youngest university - University North. In addition to his interest in clinical, research and lecturing activities, his immense passion for medical writing and scientific communication goes back to his student days. He enjoys contributing back to the community. In his spare time, Tomislav is a movie buff and an avid traveler.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Meštrović, Tomislav. (2021, February 17). Listeria Treatments. News-Medical. Retrieved on February 25, 2024 from

  • MLA

    Meštrović, Tomislav. "Listeria Treatments". News-Medical. 25 February 2024. <>.

  • Chicago

    Meštrović, Tomislav. "Listeria Treatments". News-Medical. (accessed February 25, 2024).

  • Harvard

    Meštrović, Tomislav. 2021. Listeria Treatments. News-Medical, viewed 25 February 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment